acute low back pain
Recently Published Documents


TOTAL DOCUMENTS

822
(FIVE YEARS 170)

H-INDEX

63
(FIVE YEARS 5)

Author(s):  
Marwah Y. Abdullah ◽  
Reem A. Bana ◽  
Seham O. Aldogil ◽  
Mutlaq A. Alsolami ◽  
Reem A. Alshihri ◽  
...  

Back pain has been reported as a common cause for various patients to present in an emergency or primary care settings. Besides, the management of back pain has been associated with a huge economic burden and remarkably impacts the quality of life of the affected patients. The diagnosis of acute low-back pain can be adequately achieved by conducting proper clinical evaluation and knowing the characteristics of each condition. The present review discusses the clinical evaluation and red flags for diagnosing patients presenting with acute low-back pain. An adequate examination of patients is conducted by obtaining a thorough history and successful physical examination. It should be noted that obtaining an adequate history might not be enough in some cases, and physical examination might not show any diagnostic clues. However, we also reported various red flags for detecting serious conditions, including malignancy, infections, inflammation, and others. These might help establish a further assessment of these patients, including imaging and laboratory studies. Therefore, these cases should be managed as early as possible to enhance the prognosis and intervene against any potential complications. 


Author(s):  
Juscelio Pereira da Silva ◽  
Fabiana Resende de Jesus-Moraleida ◽  
Diogo Carvalho Felício ◽  
André Gustavo Pereira de Andrade ◽  
Daniele Sirineu Pereira ◽  
...  

Author(s):  
ABDUL FAHEEM KHAN ◽  
KHANETA PARVEEN

OBJECTIVES: The objectives of this study were to compare the efficacy and safety of Tolperisone tablets 50 mg three times daily versus Tizanidine 2 mg tablets thrice daily for the treatment of acute low back pain with muscle spasm. METHODS: The comparative study was carried out in 50 patients from orthopedics Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Vijayawada. Only those patients fulfilling the inclusion/exclusion criteria were enrolled into the study. Participants suffering from acute low back pain with muscle spasm were divided into two groups. The participants were followed up on Day-14 as final analysis. RESULTS: Subjects receiving Tolperisone showed a mean value of 16.43±1.16 in the Roland Morris low back pain and disability questionnaire both groups on day 1 and was reduced to 7.82±1.15 (51.94%) on day 7 and 2.56±1.53 (84.46%) on day 14. Similarly, the patients in the tizanidine group had mean value of 15.93±1.61 on day 1, which was reduced to 6.77±1.68 (57.64%) on day 7, and 2.88±1.92 (81.95%) on day 14, as comparable to the Tolperisone group. There was no statistically significant difference between the two groups, (p>0.05) for pain at rest, pain at night, restrictions of movement, changes in stiffness, changes in numbness, and changes in tenderness. There was a statistically significant difference between the two groups, (p<0.05) for pain on movement and kinesalgia. CONCLUSIONS: Tolperisone was found comparable in efficacy to Tizanidine in improving the clinical symptoms of changes in pain Self-assessment by the patient on different applied parameters.


2021 ◽  
Vol 162 (49) ◽  
pp. 1951-1961

Összefoglaló. Nemzetközi kutatások szerint a deréktáji fájdalom 2019-ben 568 millió embert érintett világszerte. Magyarországon a lakosság 20%-a él krónikus derékfájdalommal, ami nemcsak egészségügyi, de szociális és ökonómiai krízist is jelent. A probléma aktualitását jól mutatja az is, hogy a Nemzetközi Fájdalomkutatási Társaság a 2021. évet a derékfájdalomról szóló globális évnek kiáltotta ki. A derékfájdalmak megfelelő kezelése és a krónikussá válás megelőzése tehát kiemelten fontos. Ebben nyújthatnak segítséget az evidenciákon alapuló irányelvek. Magyarországon azonban jelenleg nincs hatályos, egységes irányelv, mely a derékfájdalmakkal, azon belül is a krónikus derékfájdalom kezelésével foglalkozna. A jelen közleményben a krónikus derékfájdalom evidenciákon alapuló diagnosztikai és kezelési lehetőségeinek áttekintését tűztük ki célul. Az irodalomkutatást követően, a jelenleg is hatályos, AGREE II. rendszer szerinti magas minőségű besorolást elérő, krónikus deréktáji fájdalomra vonatkozó, angol nyelvű nemzetközi irányelvek ajánlásainak összehasonlítását végeztük el. Tanulmányunkban hét irányelvet dolgoztunk fel (négy európai, kettő amerikai, egy kanadai), melyek mindegyikében a következő közös ajánlások kerültek megfogalmazásra: a súlyos patológiák kizárása az alarm tünetek alapján, a pszichoszociális tényezők figyelembevétele, a szükségtelen képalkotó vizsgálat visszaszorítása, az elsősorban aktív, nem gyógyszeres terápiák preferálása és a nemszteroid gyulladáscsökkentők körültekintő felírása. Az európai irányelvekben új elemként szerepelt a krónikussá válás korai rizikóbecslése. Orv Hetil. 2021; 162(49): 1951–1961. Summary. In 2019, low back pain caused the highest burden globally, among musculoskeletal disorders, affecting 568 million people. According to Hungarian sociodemographic data, 20% of the Hungarian adults live with chronic low back pain that is a global health priority. Therefore, the International Association for the Study of Pain announced 2021 as the global year about back pain. Evidence-based guidelines about the appropriate treatment of acute low back pain and prevention of chronic low back pain are therefore of paramount importance. However, there are currently no valid, uniform treatment guidelines in Hungary about acute and chronic lower back pain. In this paper, we aimed at summarizing up-to-date, evidence-based diagnostic and treatment recommendations for chronic low back pain. Using a literature review, we identified seven international treatment guidelines (four from Europe, two from the United States and one from Canada) in English for the management of chronic low back pain that were previously assessed by the AGREE II quality assessment tool. We found consistent recommendations in the guidelines such as exclusion of alarm symptoms, assessment of psycho-social factors, reduction of unnecessary imaging, initialization of primarily active, non-pharmacological therapies, and careful and cautious prescription of non-steroidal anti-inflammatory medications. A new recommendation in the European guidelines is the early risk assessment of low back pain becoming chronic. Orv Hetil. 2021; 162(49): 1951–1961.


2021 ◽  
Vol 10 (23) ◽  
pp. 5569
Author(s):  
Tobias Lange ◽  
Niklas Deventer ◽  
Georg Gosheger ◽  
Lukas P Lampe ◽  
Sebastian Bockholt ◽  
...  

The aim of this study was to investigate the effect of radial extracorporeal shockwave therapy (rESWT) primarily on acute lumbar back pain (aLBP), and secondarily on physical function and quality of life. This randomized, placebo-controlled, single-blinded trial with 12-week follow-up (FU) randomized 63 patients with aLBP 1:1 into two groups receiving either rESWT (intervention) or sham rESWT (placebo) with a manipulated shockwave head not delivering any shockwaves. Both, rESWT and sham procedure were carried out eight times for four weeks. Both groups received additional analgesics and physiotherapy twice a week. Primary patient-reported outcome measure (PROM) was the visual analogue scale for aLBP (VAS-LBP). Secondary PROMs included the Oswestry disability index (ODI), Roland and Morris Disability Questionnaire (RDQ), EuroQol EQ-5D-3L, and the Beck Depression Index (BDI-II). Primary endpoint was a between-arm comparison of mean changes in VAS-LBP from baseline to final FU. At randomization, there were no differences between the two groups in relation to age and PROMs. Both groups showed significant improvement in all PROMs at final FU. VAS-LBP declined by 60.7% (p < 0.001) in the intervention and by 86.4% (p < 0.001) in the sham group. The intervention group showed significantly less pain relief after 4 and 12 weeks. The EQ-5D submodality pain showed significantly inferior results for the intervention (1.5 (0.58)) compared to the sham group (1.1 (0.33)) (p < 0.014) after eight weeks. No significant intergroup differences were observed for RDQ, ODI or BDI-II. Additional rESWT alongside conventional guideline therapy in aLBP does not have any significant effects on pain intensity, physical function, or quality of life. To the best of our knowledge, this is the first study with a high level of evidence reporting the efficacy of rESWT in aLBP treatment and will be a future basis for decision-making.


2021 ◽  
Vol 6 (3) ◽  
pp. 77-81
Author(s):  
Yamila Navarro Caboverde ◽  
Graciela Córdova García ◽  
Hansel Salas Ferrer ◽  
Lidice Ruiz Benitez ◽  
Anabel Sánchez Saname

Introduction: acupuncture and cupping constitute an alternative therapy to alleviate different conditions, especially acute low back pain, which improves the level of satisfaction and impacts on the quality of life of patients who suffer from it. Objective: to evaluate the efficacy of treatment with acupuncture and cupping in patients with acute low back pain. Methods: a randomized phase III therapeutic clinical trial was carried out in patients who attended the Natural and Traditional Medicine service of the rehabilitation room of the Juan Manuel Páez Inchauthi Polyclinic, in the municipality of Moa, Holguín province, Cuba, in the period of July to December of the year 2017. The study universe consisted of 80 patients who attended the consultation; The sample was randomly selected and consisted of 60 patients in two study groups, group I, who received acupuncture treatment, and group II, with cupping, made up of 30 patients each. Both were diagnosed with post Bi syndrome. Results: men predominated in the study, with 63.3%, and study group II, with 66.7%. The age group from 40 to 49 years was the most affected. In both, the exogenous wind factor predominated. It was observed that the Bi wind syndrome is the most benefited with acupuncture therapy, as when the suction cup was applied. Conclusion: in both groups there was 100% effectiveness of acupuncture therapy and the cupping, in the improvement or cure of acute low back pain.


2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Bara A. Shraim ◽  
Muath A. Shraim ◽  
Ayman R. Ibrahim ◽  
Mohamed E. Elgamal ◽  
Basem Al-Omari ◽  
...  

Abstract Background Clinical guideline recommendations are against early magnetic resonance imaging (eMRI) within the first 4 to 6 weeks of conservative management of acute low back pain (LBP) without “clinical suspicion” of serious underlying conditions (red flags). There is some limited evidence that a significant proportion of patients with LBP receive eMRI non- indicated by clinical guidelines, which could be associated with increased length of disability (LOD). The aim of this systematic review was to investigate whether eMRI for acute LBP without red flags is associated with increased LOD. The LOD was defined as the number of disability days (absence from work). Methods Medline, EMBASE, and CINAHL bibliographic databases were searched from inception until June 5, 2021. Two reviewers independently assessed the methodological quality of included studies using the Newcastle–Ottawa scale and extracted data for the review. The search identified 324 records, in which seven studies met the inclusion criteria. Three of the included studies used the same study population. Owing to between-study heterogeneity, a narrative synthesis of results was used. Results All included studies were of good methodological quality and consistently reported that patients with acute LBP without red flags who received eMRI had increased LOD compared to those who did not receive eMRI. Three retrospective cohort studies reported that the eMRI groups had a higher mean LOD than the no eMRI groups ranging from 9.4 days (95% CI 8.5, 10.2) to 13.7 days (95% CI 13.0, 14.5) at the end of 1-year follow-up period. The remaining studies reported that the eMRI groups had a higher hazard ratio of work disability ranging between 1.75 (95% CI 1.23, 2.50) and 3.57 (95% CI 2.33, 5.56) as compared to the no eMRI groups. Conclusion eMRI is associated with increased LOD in patients with acute LBP without red flags. Identifying reasons for performing non-indicated eMRI and addressing them with quality improvement interventions may improve adherence to clinical guidelines and improve disability outcomes among patients with LBP.


Author(s):  
Sagun Tiwari ◽  
Namrata Sapkota

Acupuncture is often used for acute and chronic low back pain; however, its efficacy is controversial, primarily for acute low back pain (ALBP). Our case study suggests that single acupuncture could relieve ALBP within a short time without any adverse events.


2021 ◽  
Vol 72 (5) ◽  
Author(s):  
Andrea PERNA ◽  
Caterina FUMO ◽  
Luca PROIETTI ◽  
Maria B. BOCCHI ◽  
Gianfranco ZIRIO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document